ACHV is trading 5.5% down at $6.16 on profit-taking following a sharp rally driven by expanded share authorization.
- Shareholders recently approved doubling authorized common shares from 150 million to 300 million, providing future financing flexibility for the company's smoking-cessation drug program.
- The pullback coincides with broader U.S. market weakness as indices trade lower amid geopolitical tensions and macro uncertainty regarding Federal Reserve policy.